143 related articles for article (PubMed ID: 12800825)
1. Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095.
Moyle GJ
AIDS Read; 2003 May; 13(5):223-4, 227, 244. PubMed ID: 12800825
[No Abstract] [Full Text] [Related]
2. Trizivir on the market.
Kerr C
Trends Microbiol; 2001 Jan; 9(1):13. PubMed ID: 11166234
[No Abstract] [Full Text] [Related]
3. Effect of co-formulated zidovudine, lamivudine and abacavir (Trizivir) on antiretroviral-naive patients presenting with advanced HIV-1 infection.
Seaton RA; Fox R; Bodasing N; Peters SE; Gourlay Y
AIDS; 2003 Feb; 17(3):445-7. PubMed ID: 12556701
[No Abstract] [Full Text] [Related]
4. Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Trizivir vs. efavirenz: results from ACTG 5095.
Feinberg J
AIDS Clin Care; 2003 Sep; 15(9):78-9. PubMed ID: 14669723
[TBL] [Abstract][Full Text] [Related]
5. AIDS drug in halted trial less effective as monotherapy.
AIDS Read; 2003 Apr; 13(4):159. PubMed ID: 12741364
[No Abstract] [Full Text] [Related]
6. Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Shey MS; Kongnyuy EJ; Alobwede SM; Wiysonge CS
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD005481. PubMed ID: 23543540
[TBL] [Abstract][Full Text] [Related]
7. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
8. Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results.
Sprenger HG; Langebeek N; Mulder PG; Ten Napel CH; Vriesendorp R; Hoepelman AI; Legrand JC; Koopmans PP; Van Kasteren ME; Bravenboer B; Ten Kate RW; Groeneveld PH; van der Werf TS; Gisolf EH; Richter C
AIDS Patient Care STDS; 2010 Jun; 24(6):361-6. PubMed ID: 20515418
[TBL] [Abstract][Full Text] [Related]
9. Conference report - antiretroviral therapy update from the 9th European AIDS Conference.
Conway B
MedGenMed; 2003 Dec; 5(4):30. PubMed ID: 14745377
[No Abstract] [Full Text] [Related]
10. Coming therapies: abacavir.
Staszewski S
Int J Clin Pract Suppl; 1999 Jun; 103():35-8. PubMed ID: 10622042
[TBL] [Abstract][Full Text] [Related]
11. New formulations approved for children.
AIDS Patient Care STDS; 2008 Jan; 22(1):88. PubMed ID: 18453043
[No Abstract] [Full Text] [Related]
12. Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
Latham V; Stebbing J; Mandalia S; Michailidis C; Davies E; Bower M; Gazzard B; Nelson M
J Antimicrob Chemother; 2005 Jul; 56(1):186-9. PubMed ID: 15911551
[TBL] [Abstract][Full Text] [Related]
13. Anatomy of a study: Trizivir vs. Sustiva.
Berger DS
Posit Aware; 2003; 14(3):40-1. PubMed ID: 12866492
[No Abstract] [Full Text] [Related]
14. Abandon Trizivir when it's working well? A rebuttal.
Erbelding EJ
Hopkins HIV Rep; 2003 Jul; 15(4):1. PubMed ID: 14696560
[No Abstract] [Full Text] [Related]
15. Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
Green H; Gibb DM; Walker AS; Pillay D; Butler K; Candeias F; Castelli-Gattinara G; Compagnucci A; Della Negra M; de Rossi A; Feiterna-Sperling C; Giaquinto C; Harper L; Levy J; Saidi Y; Wintergerst U;
AIDS; 2007 May; 21(8):947-55. PubMed ID: 17457088
[TBL] [Abstract][Full Text] [Related]
16. A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.
Shey M; Kongnyuy EJ; Shang J; Wiysonge CS
Cochrane Database Syst Rev; 2009 Jul; (3):CD005481. PubMed ID: 19588374
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV agents. Trizivir--three drugs in one pill.
TreatmentUpdate; 2000 Feb; 12(1):1-2. PubMed ID: 12125625
[No Abstract] [Full Text] [Related]
18. Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis.
Moyle GJ; Gazzard BG
AIDS; 2002 May; 16(7):1086-7. PubMed ID: 11953482
[No Abstract] [Full Text] [Related]
19. AIDS foundation seeks withdrawal of approval for HIV drug combination.
Clarke B
Lancet Infect Dis; 2003 Oct; 3(10):604. PubMed ID: 14558502
[No Abstract] [Full Text] [Related]
20. AACTG A5095, Trizivir, and the role of all-nucleoside regimens: an editorial.
Gallant JE
Hopkins HIV Rep; 2003 Jul; 15(4):1-2. PubMed ID: 14696559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
